New Delhi, June 18, 2026: The Ministry of Health and Family Welfare has introduced new regulations that require consumers to obtain a valid prescription before purchasing cough syrups and other medicinal syrups, ending their over-the-counter availability across India.
The amendment to the Drugs Rules, 1945, was notified earlier this week and is aimed at promoting the safer use of medications. While cough syrups will now require a doctor’s prescription, products such as cough lozenges, tablets, and pills will continue to be available without one.
Healthcare professionals have largely welcomed the move, citing concerns over self-medication, incorrect dosage, and the misuse of cough-and-cold formulations. Many cough syrups contain active ingredients that can cause adverse effects when used improperly or in excessive quantities, particularly among children and vulnerable patients.
However, the decision has also sparked concerns about how effectively the rules can be enforced in a country where consumers have long been accustomed to purchasing medicines directly from pharmacies without prescriptions.
Pharmacists and industry stakeholders believe implementation could face significant challenges, especially in smaller towns and local markets. Many consumers seek immediate treatment for common illnesses and may be reluctant to visit a doctor for ailments they consider minor.
Industry representatives have also pointed out that issues such as counterfeit, adulterated, and unbranded medicines continue to pose serious concerns for the pharmaceutical sector. Some argue that addressing these challenges should remain a priority alongside stricter prescription requirements.
There is also debate over whether a blanket restriction on all cough syrups will remain in place over the long term. Certain cough formulations containing controlled ingredients have already been subject to stricter regulations, while many commonly used syrups have traditionally been sold over the counter.
Pharmacy associations across several states have begun informing retailers about the new regulations and encouraging compliance. Industry bodies are also working to ensure that pharmacies, including those in remote areas, are aware of the updated requirements.
Experts believe consumer habits could become one of the biggest hurdles to implementation. Many patients often reuse old prescriptions or avoid visiting healthcare providers due to consultation costs, travel expenses, and waiting times. As a result, authorities may need to strengthen awareness campaigns and enforcement mechanisms to ensure the new rules achieve their intended objectives.
The latest policy marks a significant shift in India’s approach to regulating cough and medicinal syrups and is expected to influence both consumer behavior and pharmacy practices in the coming months.
Author
About the Author
